Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Clinical Trial

Nektar Therapeutics Stock Rockets 19% on Strong 52-Week Alopecia Areata Data for Lead Drug Candidate

Shares of Nektar Therapeutics surged more than 19% in early Monday trading on April 20, 2026, climbing $16.58 to $101.44 as investors cheered positive 52-week topline results from the Phase 2b REZOLVE-AA clinical trial of the company's lead immunology candidate, rezpegaldesleukin, in patients with severe-to-very-severe alopecia areata.

International Business Times

India wants 1,000 new clinical trial sites. Patients are still being left in the dark

Thirty-five-year-old Ritu Bhalla was twice diagnosed with blood cancer, at the ages of four and 11. She developed chronic hepatitis B as a long-term side-effect after cancer treatment.

Newslaundry

Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help

The state’s effort will get a boost from the federal government thanks to a new executive order from President Donald Trump.

The Texas Tribune

From analysis to the latest developments in health,
read the most diverse news in one place.

‘We have six months to save our daughter’s life before childhood dementia robs her of her future’

Family of two-year-old face the ultimate ‘race against time’ as they fight to access life-saving treatment before it is too late

The Independent UK

From the lab to clinical trials – why a preventative lung cancer vaccine could soon be a reality

It’s the third most common cancer in the UK, causing tens of thousands of deaths annually. But what if the disease, often only diagnosed when it’s too late, could be stopped before it even begins?

The Guardian - UK

Pfizer and Valneva's Lyme disease vaccine shows 70% efficacy in clinical trial

Pfizer and Valneva's Lyme disease vaccine has shown promising results in clinical trials, paving the way for regulatory approval despite setbacks due to fewer cases than expected, according to the companies.

Euronews

Masked T-cell engagers: cancer immunotherapies for the future?

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a “masked T-cell engager”. This type of immunotherapy ignites our own immune arsenal to fight cancer.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

'It could revolutionize, completely, the way we treat depression': Researchers are exploring promising immune therapy for treating psychiatric symptoms

Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.

LiveScience

UK health official recused from puberty blockers trial after bias claims

MHRA says Prof Jacob George will no longer be involved after gender-critical social media posts from last year

The Guardian - UK

New prostate cancer drug showing ‘remarkable’ results during clinical trial

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour

The Independent UK

‘A miracle baby’: Newborn Hugo rewrites medical history after groundbreaking womb transplant

A tiny baby named Hugo has quietly made medical history in the UK. And yet, at its heart, this isn’t really a story about science. It’s about a mother who finally got to hold the child she once believed she would never have. Hugo was born just before Christmas 2025…

Times Life

New oral pill beats previous alternatives and shows 8% weight loss in clinical trials

Eli Lilly’s new oral pill, orforglipron, led to up to 8% weight loss in clinical trials, outperforming existing oral semaglutide alternatives.

Euronews

UK clinical trial into puberty blockers on hold after medicines regulator steps in

Recruitment of children for study delayed after MHRA warns that participants should be no younger than 14

The Guardian - UK

Grail Stock Is Deeply Oversold on Cancer Test Failings. Is There Any Hope Left to Buy the Dip?

Grail stock crashed on Friday after its NHS-Galleri clinical trial failed to meet primary endpoint. Here’s why investors are cautioned against treating GRAL shares as a bargain.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Clinical trial into puberty blockers paused after ‘new concerns’ from medicines regulator

The MHRA will now discuss the concerns, related to the wellbeing of children and young people with gender dysphoria, with trial sponsor King’s College London next week

Evening Standard

Clinical trial into puberty blockers paused after ‘new concerns’ from regulator

It comes after legal action was launched against the Government after campaigners including Harry Potter author JK Rowling expressed their opposition

The Independent UK

Stroke victim with just one rare symptom highlights unusual signs of condition

Gordon Robb, a former vice-president of a biotech company, is taking part in a new British Heart Foundation-funded clinical trial.

Reason

Clinical Trials Show Moderna's New mRNA Flu Vaccine Is Safe and Effective. FDA Won't Even Consider It.

An overzealous government agency suppresses medical innovation yet again.

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Sanofi CEO: The enterprise AI shift will reshape pharma in 2026

At Sanofi, AI has shifted from experimentation to becoming a vital part of our infrastructure.

Evening Standard

Wes Streeting ‘not comfortable’ with puberty blocker clinical trial

The Health Secretary made a ban on puberty blockers indefinite in December last year.

Evening Standard

Innovative therapy gives hope to patients whose blood cancer ‘seemed incurable’

Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now disease-free.

Benzinga

Kymera Stock Smashes 52-Week High As New Pill Crushes Eczema Markers

Kymera Therapeutics, Inc. (NASDAQ:KYMR) on Monday released clinical results from the BroADen Phase 1b atopic dermatitis (AD) clinical trial of KT-621, its oral STAT6 degrader medicine.

Benzinga

What's Up With The Jump In Viking Therapeutics Stock?

Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biopharmaceutical company seems to be benefitting from wider excitement in the obesity treatment area, as well as recent positive momentum after major clinical trial developments.

The Independent UK

‘Next generation’ treatment to cure leukaemia given NHS approval

‘The biggest thing it offers is hope,’ says patient involved in clinical trial which cured cancer in significant portion of leukaemia sufferers

The Guardian - UK

Two UK clinical trials to assess impact of puberty blockers in young people

Multi-year studies announced after Cass review found ‘insufficient evidence’ about effects on children with gender dysphoria

1 2 3 4 5

People

Katharine Neill Harris

13 stories

Steve Powell

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.